Skip to content

Detection and clinical meaning of biopsy for SLN in endometrial cancer patients

Detection and clinical meaning of biopsy for SLN in endometrial cancer patients - SLN biopsy in endometrial cancer patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000014478
Enrollment
50
Registered
2014-07-30
Start date
2014-09-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endometrial cancer

Interventions

None listed

Sponsors

Tohoku University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Uterine endometrial cancer Stage 1-2(FIGO criteria)

Exclusion criteria

Exclusion criteria: bad general condition (performance status 2-4)

Design outcomes

Primary

MeasureTime frame
Detection rate of lymph node metastasis

Countries

Japan

Contacts

Public ContactAsami Toki

Tohoku University Hospital Gynecology

asa_tannpopo_pon@yahoo.co.jp022-717-7254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026